Suppr超能文献

[放射治疗与乳房植入物延迟乳房重建:兼容性研究]

[Radiotherapy and delayed breast reconstruction with implant: examination of compatibility].

作者信息

Fodor János, Gulyás Gusztáv, Polgár Csaba, Major Tibor, Szabó Eva, Köves István, Pólus Károly, Németh György, Kásler Miklós

机构信息

Országos Onkológiai Intézet, Sugárterápiás Osztály, Budapest, Hungary.

出版信息

Magy Onkol. 2002;46(4):323-6. Epub 2003 Feb 1.

Abstract

PURPOSE

Delayed breast reconstruction with implant is frequently used after mastectomy. However, given that many breast cancer patients receive adjuvant radiotherapy, the adaptation of this method raises questions concerning possible cumulative complications. In the present study the compatibility of post-mastectomy radiotherapy and delayed breast reconstruction with implant was examined.

PATIENTS AND METHODS

We evaluated a consecutive series of 66 invasive breast cancer patients who have received delayed breast reconstruction with implant after modified radical mastectomy between January 1997 and June 1999. The average time was 51 months from primary surgery to reconstruction. The median dose of loco-regional irradiation was 50 Gy. Grade III atrophic dermatitis was observed in none of the irradiated women. We identified two patient groups: 29 patients did not and 37 patients did receive post-mastectomy radiotherapy. The types and time of reconstruction related chronic complications (capsular contracture, defect of implant shell and skin necrosis) were recorded. Incidence of complications was estimated by the Kaplan-Meier method. Cancer related events were also studied.

RESULTS

When expander was used, minor discomfort of the patients was common during the filling course. At four (11%) irradiated patients the expansion with expander was incomplete, due to severe pain. At a median follow up time of 53 months the incidence of capsular contracture was 24.1% without and 29.7% with radiotherapy (p=0.4121). The five-year estimated rate of late complications was 40% and 50%, respectively (relative risk: 1.29, 95% confidence interval: 0.58-2.89, p=0.5173). The position of implant had an impact on the incidence of capsular contracture: 46.2% with subcutaneous and 22.6% with submuscular position (p=0.0881). Four patients (6%) developed local relapse (three in the skin and one subcutaneous). All were treated with tumor excision without implant removal.

CONCLUSION

Delayed breast reconstruction with implant after post-mastectomy radiotherapy can be offered to patients who are interested in breast reconstruction and had no severe late radiation skin toxicity. Post-mastectomy radiotherapy does not significantly increase the risk of complications. The use of skin expander is less tolerated by irradiated patients. Submuscular position of implants moderates the risk of capsular contracture.

摘要

目的

乳房切除术后常采用植入物进行延迟性乳房重建。然而,鉴于许多乳腺癌患者接受辅助放疗,这种方法的适用性引发了关于可能的累积并发症的问题。在本研究中,对乳房切除术后放疗与植入物延迟性乳房重建的兼容性进行了研究。

患者与方法

我们评估了1997年1月至1999年6月期间连续的66例浸润性乳腺癌患者,这些患者在改良根治性乳房切除术后接受了植入物延迟性乳房重建。从初次手术到重建的平均时间为51个月。局部区域照射的中位剂量为50 Gy。在接受照射的女性中均未观察到III级萎缩性皮炎。我们确定了两个患者组:29例患者未接受乳房切除术后放疗,37例患者接受了乳房切除术后放疗。记录了重建相关慢性并发症(包膜挛缩、植入物外壳缺陷和皮肤坏死)的类型和时间。采用Kaplan-Meier方法估计并发症的发生率。还研究了与癌症相关的事件。

结果

使用扩张器时,患者在填充过程中常见轻微不适。4例(11%)接受照射的患者因严重疼痛,扩张器扩张不完全。在中位随访时间53个月时,未接受放疗者包膜挛缩的发生率为24.1%,接受放疗者为29.7%(p = 0.4121)。晚期并发症的五年估计发生率分别为40%和50%(相对风险:1.29,95%置信区间:0.58 - 2.89,p = 0.5173)。植入物的位置对包膜挛缩的发生率有影响:皮下植入者为46.2%,肌下植入者为22.6%(p = 0.0881)。4例患者(6%)出现局部复发(3例在皮肤,1例在皮下)。所有患者均接受了肿瘤切除,未取出植入物。

结论

对于有乳房重建意愿且无严重晚期放射性皮肤毒性的患者,可在乳房切除术后放疗后进行植入物延迟性乳房重建。乳房切除术后放疗不会显著增加并发症风险。接受照射的患者对皮肤扩张器的耐受性较差。植入物置于肌下可降低包膜挛缩的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验